GNI Group Ltd. (2160.T)
GNI Group Ltd., engages in the research, development, manufacturing, and sale of pharmaceuticals and biomaterials in Japan, China, and the United States.
2,475.00+0.06%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-11.4%
The outlook
GNI Group Ltd. currently reads as leaning bearish based on below its 50- & 200-day averages, 22% of the way from its 52-week low to high, avg target +78% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range22% of the way from its 52-week low to high
Price targetAvg target +78% vs current price
Analyst price target
~12-month · 2 analysts4,400.00average target+77.8% vs now
Now 2,475.00
Low 3,800.00High 5,000.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$162.86B
52-wk high
3,740.00
52-wk low
2,112.00
50-day avg
2,627.74
200-day avg
2,716.57
Trailing P/E
—